July 13, 2020
Weil is advising Benefytt Technologies, Inc., a developer and operator of private e-commerce health insurance marketplaces, consumer engagement platforms, agency technology systems and insurance policy administration platforms, in its $625 million take-private sale to funds affiliated with Madison Dearborn Partners, LLC. The transaction is expected to close in the third quarter 2020, subject to the successful tender of a majority of the then outstanding shares of Benefytt’s common stock and the satisfaction of other customary closing conditions.
The Weil team advising Benefytt Technologies, Inc. is led by Mergers & Acquisitions partner Michael Aiello and includes Mergers & Acquisitions partner Eoghan Keenan and Mergers & Acquisition associates Adam Hassan, Michelle Sargent, Shane Safer and Karl de la Roche. The team also includes Tax Head Joseph Pari; Executive Compensation & Benefits partner Amy Rubin; Banking & Finance partner Allison Liff; Technology & IP Transactions Head Michael Epstein; Antitrust partner John Scribner; Tax counsel Eric Remijan; Tax associate Maria Browning (Not Yet Admitted in New York); Executive Compensation & Benefits associates Amanda Rosenblum and Emily Gulyako; Banking & Finance associate Anna McEwen; Technology & IP Transactions associates Dennis Adams and Caleb Small (Not Yet Admitted in New York); and Antitrust associate Richard Flannery.